Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
![Imatge de Publicacions](/sites/default/files/styles/3_1_small/public/2022-11/Portada_publicacions-petita_0.jpg?h=c6980913&itok=oZMso2V6)
The Aging Imageomics Study: rationale, design and baseline characteristics of the study population.
The EuroSIDA study: 25 years of scientific achievements.
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping.
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients.
Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing.
HIV-1 Gag mutations alone are sufficient to reduce darunavir susceptibility during virological failure to boosted PI therapy.
A Summary of the Fourth Annual Virology Education HIV Microbiome Workshop.
Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A Systematic Review of Detection Methods, Prevalence, and Clinical Impact.